ANDA Sponsors May Receive Early Notification Of Upcoming Actions, Woodcock Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Concept would allow more time for sponsors to make launch plans and could help improve communication under GDUFA.
You may also be interested in...
Generic Drug Sponsors Seek Advance Notice Of Approvals From US FDA
Pre-launch communication from agency would allow sponsors to ramp up commercial activities and could head off some innovator company legal challenges to ANDA approvals, attorneys say; CDER’s Moscicki suggests GDUFA goal dates now provide sponsors some level of predictability.
Generic Drug Sponsors Seek Advance Notice Of Approvals From US FDA
Pre-launch communication from agency would allow sponsors to ramp up commercial activities and could head off some innovator company legal challenges to ANDA approvals, attorneys say; CDER’s Moscicki suggests GDUFA goal dates now provide sponsors some level of predictability.
Late-Cycle Approval Predictions Not A Good Idea, FDA Says
OND Director John Jenkins says the late-cycle meeting in the new PDUFA review model will offer a lot of information to sponsors, but likely will not be predictive of application approvability.